Status:
COMPLETED
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Early-onset gastric cancer (EOGC) is a lethal malignancy with a poor prognosis. It differs from late-onset gastric cancer (LOGC) in clinical and molecular characteristics. The current strategies for E...
Detailed Description
Due to widespread gastric cancer (GC) detection efforts and timely interventions (removal of precancerous lesions and early-stage GC), the GC-associated mortality rate has declined worldwide. However,...
Eligibility Criteria
Inclusion
- Having signed informed consent
- 50 years old ≥ Age ≥ 18 years old
- Histologically confirmed gastric adenocarcinoma
Exclusion
- Other previous malignancy within 5 year
- Surgery (excluding diagnostic biopsy) within 4 weeks prior to study
- Pregnancy or lactation period
- Legal incapacity
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06023121
Start Date
January 1 2018
End Date
August 30 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital Ethics Committee
Beijing, Beijing Municipality, China, 100853